20 LATEST RESOURCES (1835 INDEXED)
Sex Differences in the Effects of Repeated Ketamine Infusions on Bone Markers in Patients with Unipolar and Bipolar Depression · March 2024
Articles
Biology of Sex Differences
Hippocampal Volume Changes After (R,S)-Ketamine Administration in Patients with Major Depressive Disorder and Healthy Volunteers · February 2024
Articles
Scientific Reports
Patient Perspectives and Experiences with Psilocybin Treatment for Treatment-Resistant Depression: A Qualitative Study · February 2024
Articles
Scientific Reports
Electroacupuncture versus Escitalopram for Mild to Moderate Post-Stroke Depression: A Randomized Non-Inferiority Trial · February 2024
Articles
Frontiers in Psychiatry
Ketamine for Adults with Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update · January 2024
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study · January 2024
Articles
Journal of Clinical Medicine
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature · January 2024
Articles
Journal of Clinical Medicine
Efficacy and Safety of Zuranolone in the Treatment of Major Depressive Disorder: A Meta-Analysis · January 2024
Articles
Frontiers in Neuroscience
Efficacy and Tolerability of Zuranolone in Patients with Depression: A Meta-Analysis of Randomized Controlled Trials · January 2024
Articles
Frontiers in Pharmacology
Comparison of Brexpiprazole, Aripiprazole, and Placebo for Japanese Major Depressive Disorder: A Systematic Review and Network Meta-Analysis · January 2024
Articles
Neuropsychopharmacology Reports
Use of Ketamine for Treatment Resistant Depression: Updated Review of Literature and Practical Applications to a Community Ketamine Program in Edmonton, Alberta, Canada · January 2024
Articles
Frontiers in Psychiatry
Subcutaneous Ketamine Infusion in Palliative Patients for Major Depressive Disorder (SKIPMDD)-Phase II Single-Arm Open-Label Feasibility Study · November 2023
Articles
PLOS ONE
Hippocampal Subfield Volumes in Treatment Resistant Depression and Serial Ketamine Treatment · October 2023
Articles
Frontiers in Psychiatry
ICEBERG Study: An Indirect Adjusted Comparison Estimating the Long-Term Benefit of Esketamine Nasal Spray When Compared with Routine Treatment of Treatment Resistant Depression in General Psychiatry · October 2023
Articles
Frontiers in Psychiatry
The Montreal Model: An Integrative Biomedical-Psychedelic Approach to Ketamine for Severe Treatment-Resistant Depression · September 2023
Articles
Frontiers in Psychiatry
Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
Reductions in Anxiety and Depression Symptoms in a Subset of Outpatients with Problematic Substance Use Who Received Ketamine-Assisted Psychotherapy: A Two-Year Retrospective Chart Review · August 2023
Articles
Frontiers in Psychiatry
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial · August 2023
Articles
Pharmaceutics
The Efficacy and Tolerability of Inhaled Nitrous Oxide in Major Depressive Disorder: A Systematic Review and Meta-Analysis · August 2023
Abstracts
Psychopharmacology
Change in Negative Affective Bias Following a Single Ketamine Treatment for Treatment-Resistant Depression · August 2023
Articles
Depression and Anxiety